Two faulty Excedrin batches give Novartis a headache

Novartis Consumer Health Inc. and its Israeli subsidiary have recalled two batches of the pain-relieving, fever-reducing, over-the-counter drug Excedrin because the containers were found to have erroneously contained other drugs mixed in. The batches are only those marked 10120279 and 10120280, with an expiry date of July 2014. The Health Ministry, which was informed, approved the action.
The US Food and Drug Administration examined the evidence and asked the company abroad to recall the batches wherever in the world they have been found. But it stated that there have been no reported complications in any patients. Excedrin in the indicated batches are marketed in bottles and may contain stray tablets, capsules, caplets or broken tablets, which may originate from other products.
Any consumer who purchased Excedrin of one of these batches is requested to return it to a pharmacy of his convenience and will be fully reimbursed.
Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy